The study investigated the level of adherence and factors affecting adherence to antiretroviral treatment (ART).
Methods:
The study sample consisted of 300 HIV-infected patients who received ART in the Antiretroviral Clinic of Central Hospital, Agbor, Delta State, Nigeria. Self-reported adherence to ART in the previous 1 month prior to the study as well as determinants of adherence were assessed using a questionnaire.
Results:
The most frequently used ART regimen was zidovudine + lamivudine + nevirapine. On the whole, a total of 33 (11%) respondents missed 3 doses or less in the previous month prior to the survey. There was a statistically significant association between adherence to ART and marital status, source of income, and occupation (P < .05). The most commonly reported reasons for missed doses were forgetfulness (60.4%), busy daily task (18.3%), and avoiding being seen while taking medications (11%).
Conclusion:
The prevalence of adherence among the participants was high. However, more serious efforts are needed to reduce the number of in-adherent patients. Interventions to improve adherence to ART should address challenges such as forgetfulness among the patients and frequent occurrence of adverse effects and consider specific patient-related factors such as daily tasks.
KredoTVan der WaltJSSiegfriedN. Therapeutic drug monitoring of antiretrovirals for people with HIV. Cochrane Database Syst Rev. 2009;(3):cd007268.
2.
LohseNHandenABGerstoftJ. Improved survival in HIV-infected persons: consequences and perspectives. J Antimicrob Chemother. 2007;60(3):461–463.
3.
LimaVDHarriganRMurrayM. Differential impact of adherence on long-term treatment response among naïve HIV-infected individuals. AIDS. 2008;22(17):237–280.
4.
PatersonDLSwindellsSMohrJ. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.
5.
FalagasMEZarkadouliaEAPliatsikaPA. Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology. 2008;5:13.
6.
AtkinsonMJPetrozzinoJJ. An evidence-based review of treatment-related determinants of patients’ non-adherence to HIV medications. AIDS Patient Care STDS. 2009;23(11):903–914.
7.
AmmassariATrottaMPMurriR. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(suppl 3):s123–s127.
WeiserSWolfeWBangsbergD. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34(3):281–288.
10.
GidayAShiferawW. Factors affecting adherence of antiretroviral treatment among AIDS patients in an Ethiopian tertiary university teaching hospital. Ethiop Med J. 2010;48(3):187–194.
11.
EholieSPTanonAPolneauS. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Cote d’Ivoire. J Acquir Immune Defic Syndr. 2007;45(3):355–358.
12.
MaqutuDZewotirTNorthD. Factors affecting first-month adherence to antiretroviral therapy among HIV-positive adults in South Africa. Afr J AIDS Res. 2010;9(2):117–124.
13.
CarlucciJGKamangaAShenebergerR. Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr. 2008;47(5):615–622.
14.
IliyasuZKabirMAbubakarIS. Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Niger J Med. 2005;14(3):290–294.
15.
UkweCVEkwunifeOIUdeogaranyaOP. Self-reported adherence to HAART in South-Eastern Nigeria is related to patients’ use of pill box. SAHARA J. 2010;7(1):10–15.
16.
StoneVEAdelson-MittyJDuefieldCA. Adherence to protease inhibitor (PI) therapy in clinical practice: usefulness of demographics, attitudes, and knowledge as predictors [abstract 32337]. In: Program and Abstracts of the 12th World AIDS Conference (Geneva). Stockholm, Sweden: International AIDS Society; 1998:588.
17.
WagnerGJRabkinJG. Measuring medication adherence: are missed doses reported more accurately than perfect adherence?AIDS Care. 2000;12(4):405–408.
18.
GordilloVdel AmoJSorianoV. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13(13):1763–1769.
19.
ErahPOAruteJE. Adherence of HIV/AIDS patients to antiretroviral therapy in a tertiary health facility in Benin City. Afr J Pharm Pharmacol. 2008;2(7):145–152.
20.
LanièceICissMDesclauxA. Adherence to HAART and its principal determinants in a cohort of Senegalese adults. AIDS. 2003;17(suppl 3):s103–s108.
21.
Byakika-TusiimeJOyugiJHTumwikirizeWA. Adherence to HIV antiretroviral therapy in HIV+Ugandan patients purchasing therapy. Int J STD AIDS. 2005;16(1):38–41.
22.
AlticeFLMostashariFFriedlandGH. Trust and acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;28(1):47–58.
23.
SarnaAPujariSSengarAK. Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. Indian J Med Res. 2008;127(1):28–36.
24.
BachXTLongTNNgaHN. Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study. Glob Health Action. 2013;6:19570. Web site. https://dx-doi-org.web.bisu.edu.cn/10.3402/gha.v6i0.19570. Accessed Feruary 11, 2015.
25.
KleebergerCAPhairJPStrathdeeSA. Determinants of heterogenous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26(1):82–92.
26.
AiroldiMZaccarelliMBisiL. One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects. Patient Prefer Adherence. 2010;4:115–125.
27.
PhamPA. Antiretroviral adherence and pharmacokinetics: review of their roles in sustained virologic suppression. AIDS Patient Care STDS. 2009;23(10):803–807.
28.
LiuHGolinCMillerL. A comparison study of multiple measure of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968–977.
29.
NieuwkerkPTOortFJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic response. J Autoimmune Defic Syndr. 2005;38(4):445–448.
30.
SullivanPSCampsmithMLNakamuraGV. Patient and regimen characteristics associated with self-reported non-adherence to antiretroviral therapy. PLoS One. 2007;2(6):e552.
31.
ReynoldsNRSunJNagarajaHN. Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire; a cross-protocol analysis. J Acquir Immune Defic Syndr. 2007;46(4):402–409.
